We are live on ! Find out more
KL

KCK Ltd Portfolio holdings

AUM $15.1M
1-Year Est. Return 30.14%
This Fund
S&P 500
This Quarter Est. Return
-4.43%
1 Year Est. Return
+30.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.8M
AUM Growth
-$3.53M
Cap. Flow
-$580K
Cap. Flow %
-0.91%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SGHT icon
Sight Sciences
SGHT
+$580K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGHT icon
1
Sight Sciences
SGHT
$267M
$38.5M 60.37%
4,651,165
-64,397
-1% -$580K
NPCE icon
2
Neuropace
NPCE
$505M
$25.2M 39.57%
5,621,111
RNTX
3
Rein Therapeutics
RNTX
$67.7M
$40K 0.06%
22,341

Similar funds

KCK Ltd's Q2 2023 Portfolio in Review

As of Q2 2023, KCK Ltd held 3 positions worth $63.8M, down 5.2% from $67.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. KCK Ltd opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KCK Ltd's biggest Q2 2023 reduction was Sight Sciences, cutting an estimated $580K.
  • KCK Ltd's ten largest holdings make up 100% of its $63.8M portfolio in Q2 2023.
  • KCK Ltd opened 0 new positions and closed 0 in Q2 2023.
  • KCK Ltd's portfolio value fell 5.2% quarter-over-quarter to $63.8M.

Based on KCK Ltd's 13F filing for Q2 2023, filed 25 Jul 2023.